211 related articles for article (PubMed ID: 23322600)
21. Impact of mixed cryoglobulinemia on patients with spontaneous hepatitis C virus clearance: A 13-year prospective cohort study.
Lee KC; Cheng YT; Lin CY; Kuo CJ; Chien RN; Yeh CT; Chang ML
Eur J Clin Invest; 2020 Jan; 50(1):e13189. PubMed ID: 31782138
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia.
Perotti M; Ghidoli N; Altara R; Diotti RA; Clementi N; De Marco D; Sassi M; Clementi M; Burioni R; Mancini N
Autoimmun Rev; 2008 Jun; 7(6):468-72. PubMed ID: 18558364
[TBL] [Abstract][Full Text] [Related]
23. Electron microscopic and immunochemical studies in a patient with hepatitis C virus infection and mixed cryoglobulinemia type II.
Szymanski IO; Pullman JM; Underwood JM
Am J Clin Pathol; 1994 Sep; 102(3):278-83. PubMed ID: 7521986
[TBL] [Abstract][Full Text] [Related]
24. Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia.
Sansonno D; Lauletta G; Nisi L; Gatti P; Pesola F; Pansini N; Dammacco F
Clin Exp Immunol; 2003 Aug; 133(2):275-82. PubMed ID: 12869035
[TBL] [Abstract][Full Text] [Related]
25. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.
De Re V; De Vita S; Sansonno D; Gasparotto D; Simula MP; Tucci FA; Marzotto A; Fabris M; Gloghini A; Carbone A; Dammacco F; Boiocchi M
Rheumatology (Oxford); 2006 Jun; 45(6):685-93. PubMed ID: 16399842
[TBL] [Abstract][Full Text] [Related]
26. The pathophysiology of HCV induced B-cell clonal disorders.
Landau DA; Saadoun D; Calabrese LH; Cacoub P
Autoimmun Rev; 2007 Sep; 6(8):581-7. PubMed ID: 17854753
[TBL] [Abstract][Full Text] [Related]
27. Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity.
Visentini M; Conti V; Cristofoletti C; Lazzeri C; Marrapodi R; Russo G; Casato M; Fiorilli M
Autoimmun Rev; 2013 Jan; 12(3):430-5. PubMed ID: 22940579
[TBL] [Abstract][Full Text] [Related]
28. IgM antibody response to the hepatitis C virus core protein in intravenous drug users.
Toniutto P; Falleti E; Gasparini V; Fabris C; Tisminetzky SG; Lombardelli T; Pacco P; Satta A; Pirisi M
Diagn Microbiol Infect Dis; 1999 Feb; 33(2):69-73. PubMed ID: 10091028
[TBL] [Abstract][Full Text] [Related]
29. Renal manifestations associated with hepatitis C virus.
Sinico RA; Fornasieri A; D'Amico G
Ann Med Interne (Paris); 2000 Feb; 151(1):41-5. PubMed ID: 10761561
[TBL] [Abstract][Full Text] [Related]
30. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.
Dammacco F; Sansonno D; Piccoli C; Racanelli V; D'Amore FP; Lauletta G
Semin Liver Dis; 2000; 20(2):143-57. PubMed ID: 10946420
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal IgM rheumatoid factor secreted by CD5-negative B cells during mixed cryoglobulinemia. Evidence for somatic mutations and intraclonal diversity of the expressed VH region gene.
Crouzier R; Martin T; Pasquali JL
J Immunol; 1995 Jan; 154(1):413-21. PubMed ID: 7527818
[TBL] [Abstract][Full Text] [Related]
33. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia.
Sansonno D; De Vita S; Iacobelli AR; Cornacchiulo V; Boiocchi M; Dammacco F
J Immunol; 1998 Apr; 160(7):3594-601. PubMed ID: 9531323
[TBL] [Abstract][Full Text] [Related]
34. Anti-nuclear antibody detection in cryoprecipitates: distinctive patterns in hepatitis C virus-infected patients.
Basile U; Gulli F; Torti E; De Matthaeis N; Colacicco L; Cattani P; Rapaccini GL
Dig Liver Dis; 2015 Jan; 47(1):50-6. PubMed ID: 25445409
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment.
Schott P; Hartmann H; Ramadori G
Histol Histopathol; 2001 Oct; 16(4):1275-85. PubMed ID: 11642746
[TBL] [Abstract][Full Text] [Related]
36. Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia.
Cacoub P; Boukli N; Hausfater P; Garbarg-Chenon A; Ghillani P; Thibault V; Musset L; Huraux JM; Piette JC
Ann Rheum Dis; 1998 Jul; 57(7):422-4. PubMed ID: 9797569
[TBL] [Abstract][Full Text] [Related]
37. Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC.
Cacoub P; Hausfater P; Musset L; Piette JC
Ann Med Interne (Paris); 2000 Feb; 151(1):20-9. PubMed ID: 10761559
[TBL] [Abstract][Full Text] [Related]
38. Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations.
de Re V; Simula MP; Pavan A; Garziera M; Marin D; Dolcetti R; de Vita S; Sansonno D; Geremia S; Toffoli G
Ann N Y Acad Sci; 2009 Sep; 1173():152-60. PubMed ID: 19758144
[TBL] [Abstract][Full Text] [Related]
39. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia.
Lenzi M; Frisoni M; Mantovani V; Ricci P; Muratori L; Francesconi R; Cuccia M; Ferri S; Bianchi FB
Blood; 1998 Mar; 91(6):2062-6. PubMed ID: 9490691
[TBL] [Abstract][Full Text] [Related]
40. Persistence of a large population of exhausted monoclonal B cells in mixed cryoglobuliemia after the eradication of hepatitis C virus infection.
Visentini M; Conti V; Cagliuso M; Siciliano G; Scagnolari C; Casato M; Fiorilli M
J Clin Immunol; 2012 Aug; 32(4):729-35. PubMed ID: 22382878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
